The Biotech IPO Boom Will Continue, Nasdaq Execs Predict

Three biotech companies have gone public in the last two days, bringing the year's tally of biotech IPOs to 30 so far. Here's what Nasdaq is predicting for the rest of this year and 2018.

Read the full post at Forbes - Pharma & Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive